Cargando…

Expression of aberrant antigens in hematological malignancies: A single center experience

BACKGROUND AND OBJECTIVE: Aberrant phenotype is a phenomenon of abnormal expression or loss of expression of cell specific lineage marker not associated with specific cell type. Aberrant phenotype expression due to genetic defects may be associated with unfavorable outcome. It can be used to determi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahni, Aneeta, Saud, Madiha, Siddiqui, Saima, Mukry, Samina Naz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954397/ https://www.ncbi.nlm.nih.gov/pubmed/29805426 http://dx.doi.org/10.12669/pjms.342.13996

Ejemplares similares

Influence of cytochrome P450 and glutathione S transferase polymorphisms on response to nilotinib therapy among chronic myeloidleukemia patients from Pakistan
por: Mukry, Samina Naz, et al.
Publicado: (2022)

Laboratory Diagnosis of Malaria: Comparison of Manual and Automated Diagnostic Tests
por: Mukry, Samina Naz, et al.
Publicado: (2017)

Evaluation of efficacy of serological methods for detection of HCV infection in blood donors: A single centre experience
por: Naz, Arshi, et al.
Publicado: (2018)

CLINICAL RELEVANCE OF EXTENDED PLATELET INDICES IN THE DIAGNOSIS OF IMMUNE THROMBOCYTOPENIA
por: Arshad, Aisha, et al.
Publicado: (2021)

COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience
por: Wilde, Lindsay, et al.
Publicado: (2020)

Possible correlation of electrochemiluminescence based numerical cut off index value with concentration of anti-SARS-CoV-2 antibody: Is it worth reporting?
por: Khawaja, Shabnum, et al.
Publicado: (2021)

Hematological malignancies complicating β-thalassemia syndromes: a single center experience
por: Alavi, Samin, et al.
Publicado: (2013)

Extracorporeal Life Support in Patients with Hematologic Malignancies: A Single Center Experience
por: Choi, Kuk Bin, et al.
Publicado: (2016)

A single-center experience of haploidentical stem cell transplantation in hematological malignancies
por: MALKAN, Ümit Yavuz, et al.
Publicado: (2022)

Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura
por: Naz, Arshi, et al.
Publicado: (2016)

Cardiotoxicity Associated With Chimeric Antigen Receptor (CAR)-T Cell Therapy for Hematologic Malignancies: A Systematic Review
por: Hanna, Kerollos S, et al.
Publicado: (2022)

Changes in Hematological, Clinical and Laboratory Parameters for Children with COVID-19: Single-Center Experience
por: Saleh, Mahasen, et al.
Publicado: (2021)

437. A Single-Center Experience of Solid versus Hematologic Malignancies in People Living with HIV
por: Daoud, Nour A, et al.
Publicado: (2022)

Cytogenetic culture failure and its causes in hematological disorders; a single centre perspective
por: Javed, Sarah, et al.
Publicado: (2023)

Chromosomal aberrations in hematological malignancies: A guide to the identification of novel oncogenes
por: Vundinti, Babu Rao, et al.
Publicado: (2011)

Genomic Uracil and Aberrant Profile of Demethylation Intermediates in Epigenetics and Hematologic Malignancies
por: Olinski, Ryszard, et al.
Publicado: (2021)

INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES – A FIVE-YEAR SINGLE CENTER EXPERIENCE
por: Buljan, Domagoj, et al.
Publicado: (2022)

A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients
por: Zaidi, Uzma, et al.
Publicado: (2020)

CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience
por: Rakha, Nahed Moawad, et al.
Publicado: (2022)

Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience
por: Sun, Wei, et al.
Publicado: (2023)

COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study
por: Wang, Xuejun Alice, et al.
Publicado: (2021)

Chimeric antigen T cell receptor treatment in hematological malignancies
por: Ali, Natasha
Publicado: (2019)

Complex Karyotype in Hematological Diseases: A 6-Year Single Centre Study from Pakistan
por: Waheed, Samra, et al.
Publicado: (2018)

Evaluation of Bloodstream Infections During Chemotherapy-Induced Febrile Neutropenia in Patients with Malignant Hematological Diseases: Single Center Experience
por: Piukovics, Klára, et al.
Publicado: (2015)

Tumorablative conditioning regimen for haploidentical stem cell transplantation in 102 children with hematologic malignancies: a single-center experience
por: Rongmu, Luo, et al.
Publicado: (2017)

360. Breakthrough Invasive Pulmonary Aspergillosis During Isavuconazole Prophylaxis in Patients with Hematologic Malignancies: A Single-Center Experience
por: Fontana, Lauren, et al.
Publicado: (2018)

Poster: CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience
por: Rakha, Nahed Moawad, et al.
Publicado: (2022)

Hema-seq reveals genomic aberrations in a rare simultaneous occurrence of hematological malignancies
por: Jeong, Dajeong, et al.
Publicado: (2023)

Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysis
por: von Kroge, Philipp H., et al.
Publicado: (2023)

HIV-associated hematologic malignancies: Experience from a Tertiary Cancer Center in India
por: Reddy, Rakesh, et al.
Publicado: (2016)

Clinical Outcomes of COVID-19 in Hematological Malignancies in Jordan : Tertiary Cancer Center Experience
por: Ababneh, Hazim, et al.
Publicado: (2021)

Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies
por: Yan, Weiqi, et al.
Publicado: (2020)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
por: Janelle, Valérie, et al.
Publicado: (2020)

PB2702: POLYPHARMACY IN HEMATOLOGY PRACTISE: A SINGLE CENTER EXPERIENCE
por: Karişmaz, Kadir, et al.
Publicado: (2023)

Mobilization of hematopoietic progenitor cells with granulocyte colony stimulating factors for autologous transplant in hematologic malignancies: a single center experience
por: Gabús, Raul, et al.
Publicado: (2011)

Aberrant overexpression of an epithelial marker, 14-3-3σ, in a subset of hematological malignancies
por: Motokura, Toru, et al.
Publicado: (2007)

Fast-FISH Detection and Semi-Automated Image Analysis of Numerical Chromosome Aberrations in Hematological Malignancies
por: Esa, Arif, et al.
Publicado: (1998)

Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies
por: Zuo, Fengli, et al.
Publicado: (2022)

Chimeric Antigen Receptor T Cell Exhaustion during Treatment for Hematological Malignancies
por: Shen, Chunyi, et al.
Publicado: (2020)

Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies
por: Yang, Zhihuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n5c5i3a380pb960f8pk55loes5